For This 4 Year Old With Acute Lymphoblastic Leukemia, Fear of Infection Has Kept Him From Being a Kid
vitalworks / Pixabay

For This 4 Year Old With Acute Lymphoblastic Leukemia, Fear of Infection Has Kept Him From Being a Kid

According to a story from mirror.co.uk, Jack Ruddock, aged four, had always been an endearing and good spirited child, but his life took a dramatic turn when he was hospitalized…

Continue Reading For This 4 Year Old With Acute Lymphoblastic Leukemia, Fear of Infection Has Kept Him From Being a Kid
The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials
peter-facebook / Pixabay

The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials

According to a story from Markets Insider, the biopharmaceutical company Camurus has recently issued an announcement indicating that the US Food and Drug Administration (FDA) has accepted the company's Investigational…

Continue Reading The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials
Family Support: Twin Sister Carries Twins for Neurofibromatosis Type 2 Patient
FotografieLink / Pixabay

Family Support: Twin Sister Carries Twins for Neurofibromatosis Type 2 Patient

According to a story from The Columbian, twins Jill Noe and Whitney Bliesner had developed a deep bond during their childhood days growing up in Oregon. However, they did not…

Continue Reading Family Support: Twin Sister Carries Twins for Neurofibromatosis Type 2 Patient
Potential Treatment for Infantile Batten Disease Earns Fast Track Designation
Pexels / Pixabay

Potential Treatment for Infantile Batten Disease Earns Fast Track Designation

According to a story from globenewswire.com, the gene and cell therapy company Abeona Therapeutics, Inc. has recently announced that its experimental gene therapy ABO-202 has earned Fast Track designation from…

Continue Reading Potential Treatment for Infantile Batten Disease Earns Fast Track Designation
Close Menu